Skip to main content
Top
Published in: European Radiology 11/2019

01-11-2019 | Hepatobiliary-Pancreas

Targeted and non-targeted liver biopsies carry the same risk of complication

Authors: Anna Maheux, Yvonne Purcell, Sana Harguem, Valérie Vilgrain, Maxime Ronot

Published in: European Radiology | Issue 11/2019

Login to get access

Abstract

Objectives

To reappraise the rate of and risk factors for complications of targeted and non-targeted US-guided liver biopsy in a large series.

Methods

We analyzed 2405 liver biopsies performed in 2137 patients (58% males, mean age 54 ± 15 years old) between January 2010 and December 2015. Biopsies were performed for focal liver lesions characterization (targeted) or chronic liver disease assessment (non-targeted). Clinical, laboratory, and technical data were recorded. For targeted biopsies, we also recorded the largest diameter, location, enhancement pattern, and pathology. Advert events were divided into marked symptoms and complications. Those requiring specific treatment (embolization or surgery) were considered as severe.

Results

A total of 1283 (53%) targeted and 1122 (47%) non-targeted biopsies were performed. Marked symptoms occurred after 134 biopsies (5.6%) (95 (7.4%) targeted and 39 (3.5%) non-targeted, p < 0.001), the most common being pain (109/134). Complications occurred after 38 biopsies (1.6%) (24 (1.9%) targeted and 14 (1.2%) non-targeted, p = 0.253) and were severe in 13 patients. In univariate analysis, prothrombin time (p = 0.006), serum creatinine level (p < 0.001), largest lesion diameter (p < 0.001), and tumor pathology (p = 0.040) were associated with the occurrence of complications but not platelet count or lesion enhancement pattern. In multivariate analysis, only the largest lesion diameter was retained (OR 1.014 [1.002–1.026], p = 0.018).

Conclusion

The rate of advert events after US-guided liver biopsy was low, with no difference between targeted and non-targeted biopsies. When focusing on targeted biopsies, the largest lesion diameter but not enhancement pattern appeared as the main risk factor.

Key Points

Targeted and non-targeted liver biopsies are associated with the same observed risk of complication.
Arterial phase hyperenhanced tumors on contrast-enhanced CT or MRI are not associated with a higher risk of complication when compared with non-hyperenhanced ones.
A high serum creatinine level is associated with a higher risk of complication and should motivate strict post-biopsy surveillance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology. 49:1017–1044CrossRef Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology. 49:1017–1044CrossRef
2.
go back to reference Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500CrossRef Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500CrossRef
3.
go back to reference European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236CrossRef European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236CrossRef
4.
go back to reference Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 67:358–380 Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 67:358–380
5.
go back to reference European Association for the Study of the Liver (EASL) (2016) EASL Clinical Practice on the management of benign tumours J Hepatol 65:386–398 European Association for the Study of the Liver (EASL) (2016) EASL Clinical Practice on the management of benign tumours J Hepatol 65:386–398
6.
7.
go back to reference Seeff LB, Everson GT, Morgan TR et al (2010) Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 8:877–883 Seeff LB, Everson GT, Morgan TR et al (2010) Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 8:877–883
8.
go back to reference McGill DB, Rakela J, Zinsmeister AR, Ott BJ (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 99:1396–1400CrossRef McGill DB, Rakela J, Zinsmeister AR, Ott BJ (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 99:1396–1400CrossRef
9.
go back to reference Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T (2013) Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Radiology. 266:226–235CrossRef Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T (2013) Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Radiology. 266:226–235CrossRef
10.
go back to reference Terjung B, Lemnitzer I, Dumoulin FL et al (2003) Bleeding complications after percutaneous liver biopsy. Digestion 67:138–145 Terjung B, Lemnitzer I, Dumoulin FL et al (2003) Bleeding complications after percutaneous liver biopsy. Digestion 67:138–145
11.
go back to reference Froehlich F, Lamy O, Fried M, Gonvers JJ (1993) Practice and complications of liver biopsy. Dig Dis Sci 38:1480–1484CrossRef Froehlich F, Lamy O, Fried M, Gonvers JJ (1993) Practice and complications of liver biopsy. Dig Dis Sci 38:1480–1484CrossRef
12.
go back to reference Mueller M, Kratzer W, Oeztuerk S et al (2012) Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol 12:1 Mueller M, Kratzer W, Oeztuerk S et al (2012) Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol 12:1
13.
go back to reference Farrell RJ, Smiddy PF, Pilkington RM et al (1999) Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol 30:580–587 Farrell RJ, Smiddy PF, Pilkington RM et al (1999) Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol 30:580–587
14.
go back to reference Patel IJ, Davidson JC, Nikolic B et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23:727–736CrossRef Patel IJ, Davidson JC, Nikolic B et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23:727–736CrossRef
15.
go back to reference Alten TA, Negm AA, Voigtländer T et al (2014) Safety and performance of liver biopsies in liver transplant recipients. Clin Transplant 28:585–589 Alten TA, Negm AA, Voigtländer T et al (2014) Safety and performance of liver biopsies in liver transplant recipients. Clin Transplant 28:585–589
16.
go back to reference Sharma P, McDonald GB, Banaji M (1982) The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol 4:451–453CrossRef Sharma P, McDonald GB, Banaji M (1982) The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol 4:451–453CrossRef
17.
go back to reference Sandrasegaran K, Thayalan N, Thavanesan R et al (2016) Risk factors for bleeding after liver biopsy. Abdom Radiol (NY). 41:643–649 Sandrasegaran K, Thayalan N, Thavanesan R et al (2016) Risk factors for bleeding after liver biopsy. Abdom Radiol (NY). 41:643–649
18.
go back to reference Filingeri V, Francioso S, Sforza D, Santopaolo F, Oddi FM, Tisone G (2016) A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? Eur Rev Med Pharmacol Sci 20:3609–3617 Filingeri V, Francioso S, Sforza D, Santopaolo F, Oddi FM, Tisone G (2016) A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? Eur Rev Med Pharmacol Sci 20:3609–3617
19.
go back to reference Vijayaraghavan GR, Vedantham S, Rangan V et al (2015) Effect of needle gauge and lobe laterality on parenchymal liver biopsy outcome: a retrospective analysis. Abdom Imaging 40:1223–1229 Vijayaraghavan GR, Vedantham S, Rangan V et al (2015) Effect of needle gauge and lobe laterality on parenchymal liver biopsy outcome: a retrospective analysis. Abdom Imaging 40:1223–1229
20.
go back to reference Kose S, Ersan G, Tatar B, Adar P, Erturk Sengel EB (2015) Evaluation of percutaneous liver biopsy complications in patients with chronic viral hepatitis. Eurasian J Med 47:161–164 Kose S, Ersan G, Tatar B, Adar P, Erturk Sengel EB (2015) Evaluation of percutaneous liver biopsy complications in patients with chronic viral hepatitis. Eurasian J Med 47:161–164
21.
go back to reference Sherman KE, Goodman ZD, Sullivan ST, Faris-Young S, for the GILF Study Group (2007) Liver biopsy in cirrhotic patients. Am J Gastroenterol 102:789–793CrossRef Sherman KE, Goodman ZD, Sullivan ST, Faris-Young S, for the GILF Study Group (2007) Liver biopsy in cirrhotic patients. Am J Gastroenterol 102:789–793CrossRef
22.
go back to reference Cadranel JF, Rufat P, Degos F (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).. Hepatology. 32:477–481 Cadranel JF, Rufat P, Degos F (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).. Hepatology. 32:477–481
23.
go back to reference Strobel D, Bernatik T, Blank W et al (2015) Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions – results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study). Ultraschall Med 36:122–131 Strobel D, Bernatik T, Blank W et al (2015) Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions – results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study). Ultraschall Med 36:122–131
24.
go back to reference McVay PA, Toy PT (1990) Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 94:747–753 McVay PA, Toy PT (1990) Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 94:747–753
25.
go back to reference Chi H, Hansen BE, Tang WY et al (2017) Multiple biopsy passes and the risk of complications of percutaneous liver biopsy. Eur J Gastroenterol Hepatol 29:36–41 Chi H, Hansen BE, Tang WY et al (2017) Multiple biopsy passes and the risk of complications of percutaneous liver biopsy. Eur J Gastroenterol Hepatol 29:36–41
26.
go back to reference Yu SC, Metreweli C, Lau WY, Leung WT, Liew CT, Leung NW (1997) Safety of percutaneous biopsy of hepatocellular carcinoma with an 18 gauge automated needle. Clin Radiol 52:907–911CrossRef Yu SC, Metreweli C, Lau WY, Leung WT, Liew CT, Leung NW (1997) Safety of percutaneous biopsy of hepatocellular carcinoma with an 18 gauge automated needle. Clin Radiol 52:907–911CrossRef
27.
go back to reference Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A (1995) Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 36:437–441CrossRef Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A (1995) Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 36:437–441CrossRef
28.
go back to reference Thampanitchawong P, Piratvisuth T (1999) Liver biopsy: complications and risk factors. World J Gastroenterol 5:301CrossRef Thampanitchawong P, Piratvisuth T (1999) Liver biopsy: complications and risk factors. World J Gastroenterol 5:301CrossRef
29.
go back to reference Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy: a multicentre retrospective study on 68 276 biopsies. J Hepatol 2:165–173 Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy: a multicentre retrospective study on 68 276 biopsies. J Hepatol 2:165–173
30.
go back to reference Kitchin DR, Del Rio AM, Woods M, Ludeman L, Hinshaw JL (2018) Percutaneous liver biopsy and revised coagulation guidelines: a 9-year experience. Abdom Radiol 43:1494–1501CrossRef Kitchin DR, Del Rio AM, Woods M, Ludeman L, Hinshaw JL (2018) Percutaneous liver biopsy and revised coagulation guidelines: a 9-year experience. Abdom Radiol 43:1494–1501CrossRef
31.
go back to reference Acedillo RR, Shah M, Devereaux PJ et al (2013) The risk of perioperative bleeding in patients with chronic kidney disease: a systematic review and meta-analysis. Ann Surg 258:901–913 Acedillo RR, Shah M, Devereaux PJ et al (2013) The risk of perioperative bleeding in patients with chronic kidney disease: a systematic review and meta-analysis. Ann Surg 258:901–913
32.
go back to reference Jalal D, Chonchol M, Targher G (2010) Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost 36:34–40CrossRef Jalal D, Chonchol M, Targher G (2010) Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost 36:34–40CrossRef
33.
go back to reference Pavord S, Myers B (2011) Bleeding and thrombotic complications of kidney disease. Blood Rev 25:271–278CrossRef Pavord S, Myers B (2011) Bleeding and thrombotic complications of kidney disease. Blood Rev 25:271–278CrossRef
34.
go back to reference Weeder PD, Porte RJ, Lisman T (2014) Hemostasis in liver disease: implications of new concepts for perioperative management. Transfus Med Rev 28:107–113CrossRef Weeder PD, Porte RJ, Lisman T (2014) Hemostasis in liver disease: implications of new concepts for perioperative management. Transfus Med Rev 28:107–113CrossRef
35.
go back to reference Myers RP, Fong A, Shaheen AA (2008) Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies: population-based study of percutaneous liver biopsy. Liver Int 28:705–712CrossRef Myers RP, Fong A, Shaheen AA (2008) Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies: population-based study of percutaneous liver biopsy. Liver Int 28:705–712CrossRef
36.
37.
go back to reference Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417–427CrossRef Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417–427CrossRef
38.
go back to reference He MQ, He MQ, Wang JF et al (2016) Vascular endothelial growth factor and cluster of differentiation 34 for assessment of perioperative bleeding risk in gastric cancer patients. Chin Med J (Engl) 129:1950 He MQ, He MQ, Wang JF et al (2016) Vascular endothelial growth factor and cluster of differentiation 34 for assessment of perioperative bleeding risk in gastric cancer patients. Chin Med J (Engl) 129:1950
39.
go back to reference Atwell TD, Smith RL, Hesley GK et al (2010) Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol 194:784–789 Atwell TD, Smith RL, Hesley GK et al (2010) Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol 194:784–789
Metadata
Title
Targeted and non-targeted liver biopsies carry the same risk of complication
Authors
Anna Maheux
Yvonne Purcell
Sana Harguem
Valérie Vilgrain
Maxime Ronot
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 11/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06227-3

Other articles of this Issue 11/2019

European Radiology 11/2019 Go to the issue